TY  - JOUR 
AU  - Gravalos, C.
AU  - Sanmartin, O.
AU  - Gurpide, A.
AU  - Espana, A.
AU  - Majem, M.
AU  - Suh Oh, Hae Jin
AU  - Aragon, I.
AU  - Segura, S.
AU  - Beato, C.
AU  - Botella, R.
PY  - 2019
SN  - 1699-048X
UR  - http://hdl.handle.net/20.500.11940/15976
AB  - Progress in the understanding of many tumors has enabled the development of new therapies, such as those targeted at specific molecules involved in cell growth (targeted therapies) or intended to modulate the immune system (immunotherapy). However,...
LA  - eng
KW  - Immunotherapy
KW  - Venereology
KW  - Humans
KW  - Consensus
KW  - Skin Diseases
KW  - Dermatology
KW  - Quality of Life
KW  - Neoplasms
KW  - Molecular Targeted Therapy
KW  - Antineoplastic Agents
TI  - Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
DO  - 10.1007/s12094-018-1953-x
T2  - Clinical & Translational Oncology
M2  - 556
KW  - CHUP
VL  - 21
ER  -